Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose.

Clinical endocrinology - 1 Aug 2006

McCallum Roland W, Parameswaran Venkat, Burgess John R

Abstract excerpt

OBJECTIVE: Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant syndrome characterized by primary hyperparathyroidism, pituitary neoplasia and foregut lineage neuroendocrine tumours. It has also been associated with premature cardiovascular death. As diabetes is a risk factor for increased cardiovascular mortality we investigated the prevalence and clinical correlates of glycaemic abnormalities in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Glucose
Share to Diabetes Mellitus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epidemiologic Methods

Share to Fasting

Share to Glucose Tolerance Test

Share to Health Surveys

Share to Homeostasis

Share to Multiple Endocrine Neoplasia Type 1

Source

Identifiers

PMID: 16886955
DOI: 10.1111/j.1365-2265.2006.02563.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose.PMID 16886955Read ↗

Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers.Semantic proximity Read ↗

Clinical studies of multiple endocrine neoplasia type 1 (MEN1)Semantic proximity Read ↗

Genotype-phenotype analysis in multiple endocrine neoplasia type 1.Semantic proximity Read ↗

[Multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical and molecular diagnosis and treatment of the associated disturbances].Semantic proximity Read ↗

Clinical Profile and Mutations Associated with Multiple Endocrine Neoplasia-Type1 (MEN1) and Their First-Degree Relatives at Risk of Developing MEN1: A Prospective Study.Semantic proximity Read ↗

Endocrine Precursor Lesions and Microadenomas of the Duodenum and Pancreas with and without MEN1: Criteria, Molecular Concepts and Clinical SignificanceSemantic proximity Read ↗

Clinical Genetic Testing and Early Surgical Intervention in Patients With Multiple Endocrine Neoplasia Type 1 (MEN 1)Semantic proximity Read ↗

Paediatric and young adult manifestations and outcomes of multiple endocrine neoplasia type 1Semantic proximity Read ↗

Genotype-negative multiple endocrine neoplasia type 1 with prolactinoma, hyperparathyroidism, and subclinical Cushing's syndrome accompanied by hyperglycemia: a case report.Semantic proximity Read ↗

Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1).Semantic proximity Read ↗

Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre databaseSemantic proximity Read ↗

Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.